O'connor BJ - Search Results

1

Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma.

Lim S, Jatakanon A, John M, Gilbey T, O'connor BJ, Chung KF, Barnes PJ. Lim S, et al. Am J Respir Crit Care Med. 1999 Jan;159(1):22-30. doi: 10.1164/ajrccm.159.1.9706006. Am J Respir Crit Care Med. 1999. PMID: 9872813 Clinical Trial.

2

Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma.

O'Connor BJ, Aikman SL, Barnes PJ. O'Connor BJ, et al. N Engl J Med. 1992 Oct 22;327(17):1204-8. doi: 10.1056/NEJM199210223271704. N Engl J Med. 1992. PMID: 1357551 Free article. Clinical Trial.

3

Effect of neutral endopeptidase inhibitor on airway function and bronchial responsiveness in asthmatic subjects.

Nichol GM, O'Connor BJ, Lecomte JM, Chung KF, Barnes PJ. Nichol GM, et al. Eur J Clin Pharmacol. 1992;42(5):491-4. doi: 10.1007/BF00314856. Eur J Clin Pharmacol. 1992. PMID: 1376694 Clinical Trial.

4

Protective effect of loop diuretics, piretanide and frusemide, against sodium metabisulphite-induced bronchoconstriction in asthma.

Yeo CT, O'Connor BJ, Chen-Worsdell M, Barnes PJ, Chung KF. Yeo CT, et al. Eur Respir J. 1992 Nov;5(10):1184-8. Eur Respir J. 1992. PMID: 1486963 Clinical Trial.

5

Greater effect of inhaled budesonide on adenosine 5'-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma.

O'Connor BJ, Ridge SM, Barnes PJ, Fuller RW. O'Connor BJ, et al. Am Rev Respir Dis. 1992 Sep;146(3):560-4. doi: 10.1164/ajrccm/146.3.560. Am Rev Respir Dis. 1992. PMID: 1519828 Clinical Trial.

6

Effect of inhaled furosemide and bumetanide on adenosine 5'-monophosphate- and sodium metabisulfite-induced bronchoconstriction in asthmatic subjects.

O'Connor BJ, Chung KF, Chen-Worsdell YM, Fuller RW, Barnes PJ. O'Connor BJ, et al. Am Rev Respir Dis. 1991 Jun;143(6):1329-33. doi: 10.1164/ajrccm/143.6.1329. Am Rev Respir Dis. 1991. PMID: 2048820 Clinical Trial.

7

Use of a fixed combination beta 2-agonist and steroid dry powder inhaler in asthma.

Barnes PJ, O'Connor BJ. Barnes PJ, et al. Am J Respir Crit Care Med. 1995 Apr;151(4):1053-7. doi: 10.1164/ajrccm.151.4.7697230. Am J Respir Crit Care Med. 1995. PMID: 7697230 Clinical Trial.

8

Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma.

Kuitert LM, Angus RM, Barnes NC, Barnes PJ, Bone MF, Chung KF, Fairfax AJ, Higenbotham TW, O'Connor BJ, Piotrowska B, et al. Kuitert LM, et al. Am J Respir Crit Care Med. 1995 May;151(5):1331-5. doi: 10.1164/ajrccm.151.5.7735582. Am J Respir Crit Care Med. 1995. PMID: 7735582 Clinical Trial.

9

Elevated levels of exhaled nitric oxide in bronchiectasis.

Kharitonov SA, Wells AU, O'Connor BJ, Cole PJ, Hansell DM, Logan-Sinclair RB, Barnes PJ. Kharitonov SA, et al. Am J Respir Crit Care Med. 1995 Jun;151(6):1889-93. doi: 10.1164/ajrccm.151.6.7767536. Am J Respir Crit Care Med. 1995. PMID: 7767536

10

Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide.

Kharitonov SA, O'Connor BJ, Evans DJ, Barnes PJ. Kharitonov SA, et al. Am J Respir Crit Care Med. 1995 Jun;151(6):1894-9. doi: 10.1164/ajrccm.151.6.7767537. Am J Respir Crit Care Med. 1995. PMID: 7767537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results